Advertisement

Latest News

Is TSW Becoming More Accepted in Dermatology? With Brad P. Glick, DO, MPH

59 minutes ago

In this interview from AAD 2026, Glick speaks about key insights on topical steroid withdrawal (TSW) and on the future of dermatology.

FDA Accepts Delgocitinib sNDA for Chronic Hand Eczema in Adolescents Aged 12–17

1 hour ago

The FDA has accepted LEO Pharma's sNDA for delgocitinib cream for moderate-to-severe chronic hand eczema in adolescents.

Invasive Treatment Options in Hypertrophic Cardiomyopathy

2 hours ago

Learn when cardiac myosin inhibitors suffice and when myectomy or alcohol ablation fits, with shared decisions at expert HCM centers.

Insights from the MAPLE Trial: Clinical Implications for oHCM Management

2 hours ago

MAPLE HCM reveals aficamten beats beta blockers in obstructive HCM, reshaping first-line therapy debates amid insurance hurdles.

Differentiating Cardiac Myosin Inhibitors: Clinical Considerations and Drug Interactions

2 hours ago

Explore how aficamten’s shorter half-life enables faster titration, flexible echo monitoring, and fewer drug interactions—making HCM treatment more patient-friendly and accessible.

Advertisement
Advertisement